Register
Login:
Share:
Email Facebook Twitter


Exclusive: Hardman & Co call the lithium market: is a change in trend happening?
Tower Resources identify 18 million barrels of contingent reserves worth $118M in Cameroon


Glaxosmithkline Share Price (GSK)



Share Price Information for Glaxosmithkline (GSK)


Share Price: 1,481.00Bid: 1,482.00Ask: 1,482.40Change: 1.80 (+0.12%)Riser - Glaxosmithkline
Spread: 0.40Spread as %: 0.03%Open: 1,479.60High: 1,486.40Low: 1,472.60Yesterday’s Close: 1,479.20

Glaxosmithkline Plc Ord 25P

Glaxosmithkline is listed in the FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 High Yield
Glaxosmithkline is part of the Medicine and Biotech Research sector

Glaxosmithkline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 96,500 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries.





Share Price SpacerPrice
1481.00
Share Price SpacerBid
1482.00
Share Price SpacerAsk
1482.40
Share Price SpacerChange
0.12%1.80
Share Price SpacerVolume
629,319
Share Price SpacerOpen
1,479.60
Share Price SpacerHigh
1,486.40
Share Price SpacerLow
1,472.60
Share Price SpacerClose
1,479.20
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 4,919.00m £72,850.39m 1,500

52 Week High 1,648.80 52 Week High Date 3-DEC-2018
52 Week Low 1,236.40 52 Week Low Date 6-FEB-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
1,852 288,157 321,125 47.166 31.40 80.00 5.40


London South East Users info for Glaxosmithkline


Users who watch GSK also watch: Lloyds, BP, Vodafone, Tesco, Barclays, RBS, HSBC, National Grid, BT, Aviva

Users who hold GSK also hold: Vodafone, BP, Lloyds, National Grid, Royal Dutch Shell B, Tesco, HSBC, Centrica, Aviva, BT


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

13-Dec-18
09:41:12
1,482.40
500
Sell* 
1,482.40
1,482.80
7,412
Trade Type:
Automatic execution

13-Dec-18
09:41:12
1,482.40
100
Buy* 
1,482.20
1,482.40
1,482
Trade Type:
Automatic execution

13-Dec-18
09:40:36
1,481.80
770
Sell* 
1,482.00
1,482.40
11.41k
Trade Type:
Ordinary




View more Glaxosmithkline trades >>

Directors Deals for Glaxosmithkline (GSK)
Trade DateActionNotifierPriceCurrencyAmountHolding
11-Dec-18Buy
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
1494.39GBX8207764
11-Dec-18Transfer From
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
08207764
11-Dec-18Buy
Trade Notifier Information for GlaxoSmithKline
Simon Dingemans held the position of CFO at GlaxoSmithKline at the time of this trade.
 Simon Dingemans
1494.39GBX819845001
View more Glaxosmithkline directors dealings >>


AllAtSea
Posts: 736
Opinion:No Opinion
Price:1,479.20
Shingrix demand
Wed 19:58
December 12th, 2018 – GlaxoSmithKline's (GSK) Shingrix vaccine shortage is expected to persist 'throughout 2019', reported Eric Sagonowsky with FiercePharma.

The unexpected demand for Shringrx during 2018 has overwhelmed the company's ability to keep inventories full, forcing it to take steps, such as implementing order limits to doctors and pharmacies.

“We need to get the vaccine supply expanded as fast as possible," GSK’s Luke Miels, global pharmaceuticals president, told analysts on the company's 3rd-quarter conference call on October 31, 2018.

https://www.precisionvaccinations.com/gsk-shingles-vaccine-shingrix-inventory-constraints-may-continue-through-2019
AllAtSea
Posts: 736
Opinion:No Opinion
Price:1,471.60
RE: Good/buy ratings
Wed 09:17
The UK link citywire.co.uk/funds-insider/news/the-expert-view-glaxosmithkline-wpp-and-ashtead/a1184352?re=60547&ea=222385&utm_source=BulkEmail_FundsInsider+DawnChorus&utm_medium=BulkEmail_FundsInsider+DawnChorus&utm_campaign=BulkEmail_FundsInsider+DawnChorus#i=2
AllAtSea
Posts: 736
Opinion:No Opinion
Price:1,489.80
RE: Big fall today!
Tue 14:59
Hmmm...

Weren't the Fool saying buy just before they tanked?

Are they hinting at sell now they have fallen out of bed?

On that basis..??
View more share chat for Glaxosmithkline (GSK) >>




Glaxosmithkline Plc Ord 25P home pageWebsite: Glaxosmithkline Plc Ord 25P
Website Description: GlaxoSmithKline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 99,300 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries. As of August 2016 it had a market capitalisation of £81 billion the fourth largest on the London Stock Exchange



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.